advertisement
11.4 Prostaglandins (23)
Showing records 1 to 23
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins3443 Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues
Schlötzer-Schrehardt U; Zenkel M; Nüsing RM
Investigative Ophthalmology and Visual Science 2002; 43: 1475-1487
3605 A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial
Dubiner HB; Mroz M; Shapiro AM; Dirks MS
Clinical Therapeutics 2001; 23: 1969-1983
3614 Comparison of latanoprost monotherapy with timolol-dorzolamide combination in patients with open-angle glaucoma or ocular hypertensio
Bron A; European Latanoprost Study Group; European latanoprost study group
Journal Français d'Ophtalmologie 2002; 25: 604-8
3617 Latanoprost and timolol combination therapy versus monotherapy: one-year randomized trial
Higginbotham EJ; Feldman R; Stiles M; DuBiner H
Archives of Ophthalmology 2002; 120: 915-922
3619 A comparison of once-daily morning versus evening dosing of concomitant latanoprost/timolol
Konstas AGP; Nakos E; Tersis I; Lallos NA; Leech JN; Stewart WC
American Journal of Ophthalmology 2002; 133: 753-757
3621 Additive effect of topical nipradilol for normal-tension glaucoma treated by unoprostone or latanoprost
Mizutani M; Takeuchi A; Koike N; Hisada Y; Suga Y; Isokawa H; Nakamura Y; Miyake G; Saito Y; Iwaki M
Japanese Journal of Clinical Ophthalmology 2002; 56: 799-803
3623 Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test
Stewart WC; Stewart JA; Crockett S; Kubilus C; Brown A; Shams N
Acta Ophthalmologica Scandinavica 2002; 80: 272-276
3624 Effects of latanoprost, prostaglandin F2α and nipradilol on isolated bovine ciliary muscle
Yoshitomi T; Yamaji K; Ishikawa H; Ohnishi Y
Japanese Journal of Ophthalmology 2002; 46: 401-405
3566 Studies on receptor binding and signal transduction pathways of unoprostone isopropyl
Bhattacherjee P; Paterson CA; Percicot C
Journal of Ocular Pharmacology and Therapeutics 2001; 17: 433-441
3567 Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a three-year follow-up: experience and incidence of side effects in a prospective study on 76 patients
Costagliola C; Del Prete A; Verolino M; Antinozzi P; Fusco R; Parmeggiani F; Mastropasqua L
Graefe's Archive for Clinical and Experimental Ophthalmology 2002; 240: 379-386
3568 Latanoprost in hemifacial spasm
Crevits L; Goethals M; Libbrecht N; Paemeleire K
Prostaglandins & other lipid mediators 2002; 67: 27-30
3569 Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension
Easthope SE; Perry CM
Drugs and Aging 2002; 19: 231-248
3570 Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a six-month, masked, multicenter trial
Fellman RL; Sullivan EK; Ratliff M; Silver LH; Whitson JT; Turner FD; Weiner AL; Davis AA
Ophthalmology 2002; 109: 998-1008
3571 Comparison of tropical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J Glaucoma 2001; 10:414-22
Goldberg I
Journal of Glaucoma 2002; 11: 275
3705 3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents
Hellberg MR; Conrow RE; Sharif NA; McLaughlin MA; Bishop JE; Crider JY; Dean WD; DeWolf KA; Pierce DR; Sallee VL
Bio-organic and Medicinal Chemistry 2002; 10: 2031-2049
3573 Use of latanoprost to reduce acute intraocular pressure rise following neodymium: YAG laser iridotomy
Liu CJ; Cheng CY; Chiang SC; Chiu AW; Chou JC; Hsu WM; Liu JH
Acta Ophthalmologica Scandinavica 2002; 80: 282-286
3574 Reduction in the number of topical medications by latanoprost for primary open-angle glaucoma
Matsumoto M; Kimura S; Kohri T; Hikita Y
Japanese Journal of Clinical Ophthalmology 2002; 56: 426-428
3575 Suppression of diurnal variation of intraocular pressure by topical latanoprost
Miyoshi M; Kumano K; Yamakawa R
Japanese Journal of Clinical Ophthalmology 2002; 56: 795-798
3576 Additive intraocular pressure lowering effect of various medications with latanoprost
O'Connor DJ; Martone JF; Mead A
American Journal of Ophthalmology 2002; 133: 836-837
3577 The efficacy of latanoprost is independent of the width of the ciliary body face
Ritch R; Ishikawa H; Rothman R; Yu G; Liebmann JM
Journal of Glaucoma 2002; 11: 239-243
3578 A retrospective review of non-responders to latanoprost
Scherer WJ
Journal of Ocular Pharmacology and Therapeutics 2002; 18: 287-291
3579 Travoprost: a new prostaglandin analogue for the treatment of glaucoma
Whitson JT
Expert Opinion in Pharmacotherapy 2002; 3: 965-977
3580 Effects of isopropyl unoprostone, latanoprost, and prostaglandin E2 on acute rise of aqueous flare in pigmented rabbits
Zhang XY; Hayasaka S; Hayasaka Y; Yanagisawa S; Nagaki Y
Ophthalmic Research 2002; 34: 90-93
